chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: the dry cough became worse and its now lasted 8 weeks and is ongoing; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (the dry cough became worse and its now lasted 8 weeks and is ongoing) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 047A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced COUGH (the dry cough became worse and its now lasted 8 weeks and is ongoing). At the time of the report, COUGH (the dry cough became worse and its now lasted 8 weeks and is ongoing) outcome was unknown.     Relevant concomitant medications were reported i.e., blood pressure medication.  Treatment information was provided i.e., cough drops   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Costochondritis, Pain
Clinical narrative: costochondritis the day after my 1st shot; still having pain from it; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COSTOCHONDRITIS (costochondritis the day after my 1st shot) and PAIN (still having pain from it) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COSTOCHONDRITIS (costochondritis the day after my 1st shot) and PAIN (still having pain from it). At the time of the report, COSTOCHONDRITIS (costochondritis the day after my 1st shot) and PAIN (still having pain from it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided No Treatment information provided    Reporter did not allow further contact
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Gait disturbance, Hypertension, Hypoaesthesia
Clinical narrative: fast heart beat; my blood pressure swings up; feeling dizzy; stumbling while walking; shortness of breath; throat swells up; tingling feeling on my left hand; numb feeling on my left hand; a rash on my back; Fever; pain on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (fast heart beat), HYPERTENSION (my blood pressure swings up), DIZZINESS (feeling dizzy), GAIT DISTURBANCE (stumbling while walking) and DYSPNOEA (shortness of breath) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, METOPROLOL, EMPAGLIFLOZIN (JARDIANCE), GLIPIZIDE, METFORMIN and CLOPIDOGREL for an unknown indication.    On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, the patient experienced PALPITATIONS (fast heart beat), HYPERTENSION (my blood pressure swings up), DIZZINESS (feeling dizzy), GAIT DISTURBANCE (stumbling while walking), DYSPNOEA (shortness of breath), PHARYNGEAL SWELLING (throat swells up), PARAESTHESIA (tingling feeling on my left hand), HYPOAESTHESIA (numb feeling on my left hand), RASH (a rash on my back), PYREXIA (Fever) and INJECTION SITE PAIN (pain on the injection site). On 07-Jun-2021, INJECTION SITE PAIN (pain on the injection site) had resolved. At the time of the report, PALPITATIONS (fast heart beat), HYPERTENSION (my blood pressure swings up), DIZZINESS (feeling dizzy), GAIT DISTURBANCE (stumbling while walking), DYSPNOEA (shortness of breath), PHARYNGEAL SWELLING (throat swells up), PARAESTHESIA (tingling feeling on my left hand), HYPOAESTHESIA (numb feeling on my left hand), RASH (a rash on my back) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided by the reporter.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Palpitations, Paraesthesia, Pharyngeal swelling, Pyrexia
Clinical narrative: fast heart beat; my blood pressure swings up; feeling dizzy; stumbling while walking; shortness of breath; throat swells up; tingling feeling on my left hand; numb feeling on my left hand; a rash on my back; Fever; pain on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (fast heart beat), HYPERTENSION (my blood pressure swings up), DIZZINESS (feeling dizzy), GAIT DISTURBANCE (stumbling while walking) and DYSPNOEA (shortness of breath) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, METOPROLOL, EMPAGLIFLOZIN (JARDIANCE), GLIPIZIDE, METFORMIN and CLOPIDOGREL for an unknown indication.    On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, the patient experienced PALPITATIONS (fast heart beat), HYPERTENSION (my blood pressure swings up), DIZZINESS (feeling dizzy), GAIT DISTURBANCE (stumbling while walking), DYSPNOEA (shortness of breath), PHARYNGEAL SWELLING (throat swells up), PARAESTHESIA (tingling feeling on my left hand), HYPOAESTHESIA (numb feeling on my left hand), RASH (a rash on my back), PYREXIA (Fever) and INJECTION SITE PAIN (pain on the injection site). On 07-Jun-2021, INJECTION SITE PAIN (pain on the injection site) had resolved. At the time of the report, PALPITATIONS (fast heart beat), HYPERTENSION (my blood pressure swings up), DIZZINESS (feeling dizzy), GAIT DISTURBANCE (stumbling while walking), DYSPNOEA (shortness of breath), PHARYNGEAL SWELLING (throat swells up), PARAESTHESIA (tingling feeling on my left hand), HYPOAESTHESIA (numb feeling on my left hand), RASH (a rash on my back) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided by the reporter.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: fast heart beat; my blood pressure swings up; feeling dizzy; stumbling while walking; shortness of breath; throat swells up; tingling feeling on my left hand; numb feeling on my left hand; a rash on my back; Fever; pain on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (fast heart beat), HYPERTENSION (my blood pressure swings up), DIZZINESS (feeling dizzy), GAIT DISTURBANCE (stumbling while walking) and DYSPNOEA (shortness of breath) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, METOPROLOL, EMPAGLIFLOZIN (JARDIANCE), GLIPIZIDE, METFORMIN and CLOPIDOGREL for an unknown indication.    On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, the patient experienced PALPITATIONS (fast heart beat), HYPERTENSION (my blood pressure swings up), DIZZINESS (feeling dizzy), GAIT DISTURBANCE (stumbling while walking), DYSPNOEA (shortness of breath), PHARYNGEAL SWELLING (throat swells up), PARAESTHESIA (tingling feeling on my left hand), HYPOAESTHESIA (numb feeling on my left hand), RASH (a rash on my back), PYREXIA (Fever) and INJECTION SITE PAIN (pain on the injection site). On 07-Jun-2021, INJECTION SITE PAIN (pain on the injection site) had resolved. At the time of the report, PALPITATIONS (fast heart beat), HYPERTENSION (my blood pressure swings up), DIZZINESS (feeling dizzy), GAIT DISTURBANCE (stumbling while walking), DYSPNOEA (shortness of breath), PHARYNGEAL SWELLING (throat swells up), PARAESTHESIA (tingling feeling on my left hand), HYPOAESTHESIA (numb feeling on my left hand), RASH (a rash on my back) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided by the reporter.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity, Pyrexia, Sluggishness
Clinical narrative: sluggish; chills; tired; sore arm; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (sluggish), CHILLS (chills), FATIGUE (tired), PAIN IN EXTREMITY (sore arm) and PYREXIA (low grade fever) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Parkinson's disease, Myasthenia gravis and Autoimmune disorder NOS. Concomitant products included PREDNISONE for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SLUGGISHNESS (sluggish), CHILLS (chills), FATIGUE (tired), PAIN IN EXTREMITY (sore arm) and PYREXIA (low grade fever). At the time of the report, SLUGGISHNESS (sluggish), CHILLS (chills), FATIGUE (tired), PAIN IN EXTREMITY (sore arm) and PYREXIA (low grade fever) had resolved.            It was reported that the events lasted for a day and half. The patient reported taking IDD treatments before the second vaccination dose.  No treatment medications were reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chills, Fatigue, Heart rate, Pyrexia
Clinical narrative: fever; chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills) and FATIGUE (Fatigue) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     The patient's past medical history included Cardiac pacemaker insertion and Stent insertion NOS (2 stents). Concomitant products included LIRAGLUTIDE, ACETYLSALICYLIC ACID (BABY ASPIRIN), CARVEDILOL, FUROSEMIDE, ATORVASTATIN, VALSARTAN and GLIPIZIDE for an unknown indication.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced PYREXIA (fever) and CHILLS (chills). 20-May-2021, the patient experienced FATIGUE (Fatigue). On 22-May-2021, PYREXIA (fever) and CHILLS (chills) had resolved. At the time of the report, FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-May-2021, Heart rate: unknown (High) Fast heartrate. On an unknown date, Blood pressure measurement: unknown (High) High blood pressure.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Myalgia
Clinical narrative: Not eating; Fever; Body ache; Headache; Fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Not eating), PYREXIA (Fever), MYALGIA (Body ache), HEADACHE (Headache) and FATIGUE (Fatigue) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced DECREASED APPETITE (Not eating), PYREXIA (Fever), MYALGIA (Body ache), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (chills). At the time of the report, DECREASED APPETITE (Not eating), PYREXIA (Fever), MYALGIA (Body ache), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment information provided.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Not eating; Fever; Body ache; Headache; Fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Not eating), PYREXIA (Fever), MYALGIA (Body ache), HEADACHE (Headache) and FATIGUE (Fatigue) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced DECREASED APPETITE (Not eating), PYREXIA (Fever), MYALGIA (Body ache), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (chills). At the time of the report, DECREASED APPETITE (Not eating), PYREXIA (Fever), MYALGIA (Body ache), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment information provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Fatigue, Herpes zoster, Nerve compression, Neuralgia
Clinical narrative: shingles (Herpes Zoster); blisters; Rash; Nerve pinch and pain; Nerve pain; exhausted; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles (Herpes Zoster)), NERVE COMPRESSION (Nerve pinch and pain), NEURALGIA (Nerve pain), BLISTER (blisters) and RASH (Rash) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACYCLOVIR [ACICLOVIR] for Shingles.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced FATIGUE (exhausted). On 22-May-2021, the patient experienced NERVE COMPRESSION (Nerve pinch and pain) and NEURALGIA (Nerve pain). On 26-May-2021, the patient experienced BLISTER (blisters) and RASH (Rash). On 29-May-2021, the patient experienced HERPES ZOSTER (shingles (Herpes Zoster)). The patient was treated with CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) for Blisters, at an unspecified dose and frequency; GABAPENTIN for Adverse event, at a dose of 300mg and PARACETAMOL (TYLENOL) (oral) for Adverse event, at a dose of 500 milligram. At the time of the report, HERPES ZOSTER (shingles (Herpes Zoster)), NERVE COMPRESSION (Nerve pinch and pain), NEURALGIA (Nerve pain), BLISTER (blisters), RASH (Rash) and FATIGUE (exhausted) outcome was unknown.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: shingles (Herpes Zoster); blisters; Rash; Nerve pinch and pain; Nerve pain; exhausted; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles (Herpes Zoster)), NERVE COMPRESSION (Nerve pinch and pain), NEURALGIA (Nerve pain), BLISTER (blisters) and RASH (Rash) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACYCLOVIR [ACICLOVIR] for Shingles.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced FATIGUE (exhausted). On 22-May-2021, the patient experienced NERVE COMPRESSION (Nerve pinch and pain) and NEURALGIA (Nerve pain). On 26-May-2021, the patient experienced BLISTER (blisters) and RASH (Rash). On 29-May-2021, the patient experienced HERPES ZOSTER (shingles (Herpes Zoster)). The patient was treated with CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) for Blisters, at an unspecified dose and frequency; GABAPENTIN for Adverse event, at a dose of 300mg and PARACETAMOL (TYLENOL) (oral) for Adverse event, at a dose of 500 milligram. At the time of the report, HERPES ZOSTER (shingles (Herpes Zoster)), NERVE COMPRESSION (Nerve pinch and pain), NEURALGIA (Nerve pain), BLISTER (blisters), RASH (Rash) and FATIGUE (exhausted) outcome was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder, Sleep problem and Acid reflux (oesophageal). Concomitant products included FAMOTIDINE for Acid reflux (oesophageal), LORATADINE for Asthma, ZOLPIDEM for Sleep problem, LEVOTHYROXINE for Thyroid disorder, APIXABAN, PAROXETINE, VITAMIN D [VITAMIN D NOS], MELATONIN, CLOZAPINE and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced FATIGUE (Tired). At the time of the report, FATIGUE (Tired) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-211414 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CLOZAPINE, ZOLPIDEM TARTRATE (AMBIEN), LEVOTHYROXINE, APIXABAN (ELIQUIS), PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), LORATADINE (CLARITINE), VITAMIN B12 NOS, VITAMIN D NOS, MELATONIN and FAMOTIDINE (PEPCID [FAMOTIDINE]) for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced FATIGUE (Tired). At the time of the report, FATIGUE (Tired) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.    This case was linked to MOD-2021-211411 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Is getting a cough one of the side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Is getting a cough one of the side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Is getting a cough one of the side effects). At the time of the report, COUGH (Is getting a cough one of the side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication was not provided by the reporter.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Over 35 days since 1st dose of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Over 35 days since 1st dose of vaccine) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Over 35 days since 1st dose of vaccine). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Over 35 days since 1st dose of vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. No treatment information was reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fall, Headache
Clinical narrative: patient had 2 falls "both happened on Sundays"; headaches; chills; burning in joints; This spontaneous case was reported by a consumer and describes the occurrence of FALL (patient had 2 falls "both happened on Sundays"), HEADACHE (headaches), CHILLS (chills) and ARTHRALGIA (burning in joints) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 031B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VALSARTAN for Blood pressure high.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced FALL (patient had 2 falls "both happened on Sundays"), HEADACHE (headaches), CHILLS (chills) and ARTHRALGIA (burning in joints). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, FALL (patient had 2 falls "both happened on Sundays"), HEADACHE (headaches), CHILLS (chills) and ARTHRALGIA (burning in joints) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitants include gummy vegetable supplement. Patient declined any symptoms after first dose.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient received first vaccine at the age of 16 years; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received first vaccine at the age of 16 years) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Autism.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received first vaccine at the age of 16 years). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received first vaccine at the age of 16 years) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   No treatment information was provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Malaise, Myalgia
Clinical narrative: didn't feel well the next day; right arm has been aching; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (didn't feel well the next day) and MYALGIA (right arm has been aching) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, the patient experienced MYALGIA (right arm has been aching). On 13-May-2021, the patient experienced MALAISE (didn't feel well the next day). At the time of the report, MALAISE (didn't feel well the next day) had resolved and MYALGIA (right arm has been aching) had not resolved.            No concomitant and treatment medications were reported.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Fever of 102; Body aches; Chills; lump under left arm pit size of a soft ball where he received his 1st shot; Whole left shoulder is swollen; Right leg is sore; Right leg is swollen to groin; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 102), MYALGIA (Body aches), CHILLS (Chills), VACCINATION SITE MASS (lump under left arm pit size of a soft ball where he received his 1st shot) and SWELLING (Whole left shoulder is swollen) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced PYREXIA (Fever of 102), MYALGIA (Body aches), CHILLS (Chills), VACCINATION SITE MASS (lump under left arm pit size of a soft ball where he received his 1st shot), SWELLING (Whole left shoulder is swollen), PAIN IN EXTREMITY (Right leg is sore) and PERIPHERAL SWELLING (Right leg is swollen to groin). At the time of the report, PYREXIA (Fever of 102), MYALGIA (Body aches), CHILLS (Chills), VACCINATION SITE MASS (lump under left arm pit size of a soft ball where he received his 1st shot), SWELLING (Whole left shoulder is swollen), PAIN IN EXTREMITY (Right leg is sore) and PERIPHERAL SWELLING (Right leg is swollen to groin) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jun-2021, Pyrexia: 102 (Inconclusive) Fever of 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No Treatments were reported.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling, Vaccination site mass
Clinical narrative: Fever of 102; Body aches; Chills; lump under left arm pit size of a soft ball where he received his 1st shot; Whole left shoulder is swollen; Right leg is sore; Right leg is swollen to groin; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 102), MYALGIA (Body aches), CHILLS (Chills), VACCINATION SITE MASS (lump under left arm pit size of a soft ball where he received his 1st shot) and SWELLING (Whole left shoulder is swollen) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced PYREXIA (Fever of 102), MYALGIA (Body aches), CHILLS (Chills), VACCINATION SITE MASS (lump under left arm pit size of a soft ball where he received his 1st shot), SWELLING (Whole left shoulder is swollen), PAIN IN EXTREMITY (Right leg is sore) and PERIPHERAL SWELLING (Right leg is swollen to groin). At the time of the report, PYREXIA (Fever of 102), MYALGIA (Body aches), CHILLS (Chills), VACCINATION SITE MASS (lump under left arm pit size of a soft ball where he received his 1st shot), SWELLING (Whole left shoulder is swollen), PAIN IN EXTREMITY (Right leg is sore) and PERIPHERAL SWELLING (Right leg is swollen to groin) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jun-2021, Pyrexia: 102 (Inconclusive) Fever of 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No Treatments were reported.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-211432 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dysuria, Fatigue, Urinary incontinence, Vaccination site pain
Clinical narrative: painful urination; urinary incontinence; pain at the injection site / still having tenderness at the injection site currently; I am tired; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of DYSURIA (painful urination), URINARY INCONTINENCE (urinary incontinence), VACCINATION SITE PAIN (pain at the injection site / still having tenderness at the injection site currently) and FATIGUE (I am tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced DYSURIA (painful urination), URINARY INCONTINENCE (urinary incontinence), VACCINATION SITE PAIN (pain at the injection site / still having tenderness at the injection site currently) and FATIGUE (I am tired). At the time of the report, DYSURIA (painful urination), URINARY INCONTINENCE (urinary incontinence), VACCINATION SITE PAIN (pain at the injection site / still having tenderness at the injection site currently) and FATIGUE (I am tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications information was not reported. Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Non-Significant follow up appended
Sex: M
Vaccine: COVID19
Symptoms: Headache, Oxygen saturation decreased, Pyrexia
Clinical narrative: fever of 103; Headache; Low oxygen level; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever of 103), HEADACHE (Headache) and OXYGEN SATURATION DECREASED (Low oxygen level) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 044B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Jun-2021, the patient experienced PYREXIA (fever of 103), HEADACHE (Headache) and OXYGEN SATURATION DECREASED (Low oxygen level). At the time of the report, PYREXIA (fever of 103), HEADACHE (Headache) and OXYGEN SATURATION DECREASED (Low oxygen level) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-211427 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Oropharyngeal pain, Rash, Vomiting
Clinical narrative: sore throat; dizziness; Horrible rash; vomits; Headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), DIZZINESS (dizziness), RASH (Horrible rash), VOMITING (vomits) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat), DIZZINESS (dizziness), RASH (Horrible rash), VOMITING (vomits) and HEADACHE (Headache). At the time of the report, OROPHARYNGEAL PAIN (sore throat), DIZZINESS (dizziness), RASH (Horrible rash), VOMITING (vomits) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information, if any, was not provided by the reporter.  Treatment information, if any, was not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Nausea, Vaccination site erythema, Vaccination site pain
Clinical narrative: The site has been very swollen after the 1st dose; Soreness at the site of injection; Redness at the site of injection; Itchiness at the site of injection; Diarrhea; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE PRURITUS (Itchiness at the site of injection), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE PRURITUS (Itchiness at the site of injection), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE SWELLING (The site has been very swollen after the 1st dose). At the time of the report, VACCINATION SITE PAIN (Soreness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE PRURITUS (Itchiness at the site of injection), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: significant follow up appended
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: The site has been very swollen after the 1st dose; Soreness at the site of injection; Redness at the site of injection; Itchiness at the site of injection; Diarrhea; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE PRURITUS (Itchiness at the site of injection), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE PRURITUS (Itchiness at the site of injection), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE SWELLING (The site has been very swollen after the 1st dose). At the time of the report, VACCINATION SITE PAIN (Soreness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE PRURITUS (Itchiness at the site of injection), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: significant follow up appended
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site nodule, Myalgia, Nausea
Clinical narrative: large knot at the site of injection; Fever; Chills; Nausea; Headache; Body aches; 3-inch circle at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE NODULE (large knot at the site of injection), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea) and HEADACHE (Headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced INJECTION SITE NODULE (large knot at the site of injection), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache), MYALGIA (Body aches) and VACCINATION SITE REACTION (3-inch circle at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE NODULE (large knot at the site of injection), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache), MYALGIA (Body aches) and VACCINATION SITE REACTION (3-inch circle at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site reaction
Clinical narrative: large knot at the site of injection; Fever; Chills; Nausea; Headache; Body aches; 3-inch circle at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE NODULE (large knot at the site of injection), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea) and HEADACHE (Headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced INJECTION SITE NODULE (large knot at the site of injection), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache), MYALGIA (Body aches) and VACCINATION SITE REACTION (3-inch circle at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE NODULE (large knot at the site of injection), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache), MYALGIA (Body aches) and VACCINATION SITE REACTION (3-inch circle at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: did not receive second dose of moderna covid 19 vaccine within 42 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (did not receive second dose of moderna covid 19 vaccine within 42 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not receive second dose of moderna covid 19 vaccine within 42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (did not receive second dose of moderna covid 19 vaccine within 42 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: possible late second dose of a series; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (possible late second dose of a series) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (possible late second dose of a series). At the time of the report, PRODUCT DOSE OMISSION ISSUE (possible late second dose of a series) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: This spontaneous case reported by a pharmacist, describes the occurrence of product dose omission issue (patient never received the second dose/not received the 2nd dose >2 months away from the first dose) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. March 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jun 7, 2021, patient experienced product dose omission issue (patient never received the second dose/not received the 2nd dose >2 months away from the first dose). At the time of the report, product dose omission issue (patient never received the second dose/not received the 2nd dose >2 months away from the first dose) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, concomitant medications or treatment information.
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Dyspnoea, Eye pain, Fatigue, Hair disorder
Clinical narrative: Speech impaired; Dominance difficulty in understanding speech,; Tired; Eyes hurting; I feel like I want to go to sleep; Eyes flashing; Breathing problems; Cramps in legs and buttocks; Hair problems; Throat is bothering me; My neck and joints is bothering me; My armpits are bothering me; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Breathing problems), MUSCLE SPASMS (Cramps in legs and buttocks), HAIR DISORDER (Hair problems), OROPHARYNGEAL DISCOMFORT (Throat is bothering me) and MUSCULOSKELETAL DISCOMFORT (My neck and joints is bothering me) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ALBUTEROL [SALBUTAMOL] and SIMETICONE (GAS RELIEF) for an unknown indication.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-May-2021, the patient experienced DYSPNOEA (Breathing problems), MUSCLE SPASMS (Cramps in legs and buttocks), HAIR DISORDER (Hair problems), OROPHARYNGEAL DISCOMFORT (Throat is bothering me), MUSCULOSKELETAL DISCOMFORT (My neck and joints is bothering me) and DISCOMFORT (My armpits are bothering me). On 07-Jun-2021, the patient experienced EYE PAIN (Eyes hurting), SOMNOLENCE (I feel like I want to go to sleep), PHOTOPSIA (Eyes flashing) and FATIGUE (Tired). On an unknown date, the patient experienced SPEECH DISORDER (Speech impaired) and MOTOR DYSFUNCTION (Dominance difficulty in understanding speech,). At the time of the report, DYSPNOEA (Breathing problems), MUSCLE SPASMS (Cramps in legs and buttocks), HAIR DISORDER (Hair problems), OROPHARYNGEAL DISCOMFORT (Throat is bothering me), MUSCULOSKELETAL DISCOMFORT (My neck and joints is bothering me), DISCOMFORT (My armpits are bothering me), EYE PAIN (Eyes hurting), SOMNOLENCE (I feel like I want to go to sleep), PHOTOPSIA (Eyes flashing), SPEECH DISORDER (Speech impaired), MOTOR DYSFUNCTION (Dominance difficulty in understanding speech,) and FATIGUE (Tired) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient states she was taking some medications for her mind, for breathing. The patient gave medications that are prescribed to her, which were not specified.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021:  updated